FdaApplication
NDA 202088
Identifiers
- fda_app_no: NDA202088
Properties
| Property | Value |
|---|---|
| applicant_name | CITIUS PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 2011-06-13 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUPRENZA | PHENTERMINE HYDROCHLORIDE | 37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
| SUPRENZA | PHENTERMINE HYDROCHLORIDE | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
| SUPRENZA | PHENTERMINE HYDROCHLORIDE | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
3 products